Antiviral mechanism of glycyrrhizic acid against BVDV: suppression of viral replication and immune regulation

Abstract

IntroductionBovine viral diarrhea virus (BVDV), a globally prevalent pathogen in cattle, causes severe economic losses through acute diarrhea, immunosuppression, and reproductive failure, with mortality rates reaching 20%–30% in persistently infected herds. This study investigated glycyrrhizic acid (GA), a bioactive triterpenoid glycoside derived from licorice root with known anti-inflammatory and broad-spectrum antiviral properties, as a potential inhibitor of BVDV replication.MethodsUsing in vitro (MDBK cells) and in vivo (BALB/c mice) models, we evaluated the antiviral and immunomodulatory effects of GA. Cells were treated with 10 μM GA, and mice received 20 mg/kg/day GA. Viral replication, cytokine expression, hepatic histopathology, and gut microbiota were assessed.ResultsGA treatment significantly reduced BVDV replication, decreasing 5’UTR and NS5B mRNA expression by >80% (P < 0.01) and viral titers by 2.3-log in liver tissue. GA concurrently modulated host immune responses, suppressing pro-inflammatory cytokines (TNF-α by 68%, IL-6 by 54%) while elevating IL-10 (2.1-fold), and substantially improved hepatic histopathology scores (P < 0.05 versus infected controls). ELISA revealed GA-mediated downregulation of IFN-β during infection. Analysis of gut microbiota at 7 days post-infection revealed that both GA and ribavirin (RBV) treatments modulated microbial community structure, with RBV showing profiles more closely resembling uninfected controls.DiscussionThese findings establish GA’s dual antiviral mechanism—direct suppression of viral RNA synthesis and immunomodulation—positioning this natural compound as a promising therapeutic candidate against BVDV infection in livestock.

Knockdown of fibrillarin reveals cell- and virus- dependent restriction of henipavirus replication and enhanced antiviral immune signalling
R. M. Sathiqu, C. Rootes, A. M. Brice +6
bioRxiv2 Nov 2026PreprintCC BYFull textMicrobiologybioRxiv
Restraint of Powassan virus replication by TRIM5α facilitates viral avoidance of antiviral immunity
Rebecca M. Broeckel, Emily A. Fitzmeyer, Eva Chebishev +20
Communications Biology7 Jul 2026Peer-reviewedCC BY 4.0Full textImmunologyPMC
A tomato fruit blotch viral replicon defines minimal requirements for cell autonomous replication and identifies functional RNA4-encoded movement and silencing suppression activities
N. Miotti, F. Bono, C. Ratti +3
bioRxiv21 May 2026PreprintCC BY-NC-NDFull textMicrobiologybioRxiv
2C-RT Quantifies Genome-Wide DNA Replication Perturbationsand Redefines RIF1-CDC7 Regulation of Replication Timing
B. Urien, P. Y. Kuwong, G. Giglio +5
bioRxiv9 Oct 2026PreprintCC BYFull textCell biologybioRxiv
Integrated in vivo and transcriptomic analyses of lethal Oropouche virus infection reveal suppression of pathogenic host responses by antiviral therapy
Cássia Sousa Moraes, Gabriel Gonzalez, Akihiko Sato +15
PLOS Pathogens7 Oct 2026Peer-reviewedCC BYFull textGenetics & genomics ImmunologyPLOSEurope PMC

Cite

BibTeX RIS

BibTeX

@article{fang2026antiviral,
  title = {{Antiviral mechanism of glycyrrhizic acid against BVDV: suppression of viral replication and immune regulation}},
  author = {Yunnan Fang and Youli Yu and Zhengqing Yu and Jiandong Wang and Zhengwei Zhao and Yanan Guo and Yuxi Zhao and Dongdong Cai and Yuqiu Yang and Pan Zhou},
  journal = {Frontiers in Microbiology},
  year = {2026},
  month = oct,
  doi = {10.3389/fmicb.2026.1924475},
  url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1924475},
  note = {CC BY 4.0},
}

RIS

TY  - JOUR
TI  - Antiviral mechanism of glycyrrhizic acid against BVDV: suppression of viral replication and immune regulation
AU  - Yunnan Fang
AU  - Youli Yu
AU  - Zhengqing Yu
AU  - Jiandong Wang
AU  - Zhengwei Zhao
AU  - Yanan Guo
AU  - Yuxi Zhao
AU  - Dongdong Cai
AU  - Yuqiu Yang
AU  - Pan Zhou
PY  - 2026
DA  - 2026/10/29
JO  - Frontiers in Microbiology
DO  - 10.3389/fmicb.2026.1924475
UR  - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1924475
AB  - IntroductionBovine viral diarrhea virus (BVDV), a globally prevalent pathogen in cattle, causes severe economic losses through acute diarrhea, immunosuppression, and reproductive failure, with mortality rates reaching 20%–30% in persistently infected herds. This study investigated glycyrrhizic acid (GA), a bioactive triterpenoid glycoside derived from licorice root with known anti-inflammatory and broad-spectrum antiviral properties, as a potential inhibitor of BVDV replication.MethodsUsing in vitro (MDBK cells) and in vivo (BALB/c mice) models, we evaluated the antiviral and immunomodulatory effects of GA. Cells were treated with 10 μM GA, and mice received 20 mg/kg/day GA. Viral replication, cytokine expression, hepatic histopathology, and gut microbiota were assessed.ResultsGA treatment significantly reduced BVDV replication, decreasing 5’UTR and NS5B mRNA expression by >80% (P < 0.01) and viral titers by 2.3-log in liver tissue. GA concurrently modulated host immune responses, suppressing pro-inflammatory cytokines (TNF-α by 68%, IL-6 by 54%) while elevating IL-10 (2.1-fold), and substantially improved hepatic histopathology scores (P < 0.05 versus infected controls). ELISA revealed GA-mediated downregulation of IFN-β during infection. Analysis of gut microbiota at 7 days post-infection revealed that both GA and ribavirin (RBV) treatments modulated microbial community structure, with RBV showing profiles more closely resembling uninfected controls.DiscussionThese findings establish GA’s dual antiviral mechanism—direct suppression of viral RNA synthesis and immunomodulation—positioning this natural compound as a promising therapeutic candidate against BVDV infection in livestock.
SN  - 1664-302X
ER  -

Abstract

Related

Cite